These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2695601)

  • 1. Natural infection of duck embryos with duck hepatitis B virus: time and tissue sequence of infection.
    Dixon RJ; Jones NF; Freiman JS; Wilson NS
    J Med Virol; 1989 Dec; 29(4):303-7. PubMed ID: 2695601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study.
    Sridhar G; Valliammai T; Varalakshmi CS; Udayasankar K; Panchanadam M; Ramakrishna J; Gopal KV; Jayaraman K; Thyagarajan SP
    Trop Anim Health Prod; 1993 Nov; 25(4):229-33. PubMed ID: 8109057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno disc assay for screening duck hepatitis B surface antigen in serum, liver tissue and cultured hepatocytes.
    de Wilde GA; Heijtink RA
    J Virol Methods; 1993 Jun; 43(1):41-51. PubMed ID: 8360315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
    Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL
    Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the kinetics of the specific cellular immune response to duck hepatitis B virus in infected and immune ducks.
    Vickery K; Cossart Y; Dixon R
    Vet Microbiol; 1999 Aug; 68(1-2):157-69. PubMed ID: 10501173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.
    Foster WK; Miller DS; Marion PL; Colonno RJ; Kotlarski I; Jilbert AR
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2624-35. PubMed ID: 12878529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response of ducks to duck hepatitis B virus infection.
    Vickery K; Cossart Y; Dixon R
    J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS; Kotlarski I; Jilbert AR
    Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of the serological assay for humoral immune response against duck hepatitis B virus.
    Tang N; Huang A; Guo S; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):13-5. PubMed ID: 11242126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron microscopic studies on duck hepatitis B virus particles in hepatocytes and sequential changes in various patterns of infection.
    Okinaga S; Fukuda R; Fukumoto S; Shimada Y
    Gastroenterol Jpn; 1991 Aug; 26(4):458-64. PubMed ID: 1916154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
    Noordeen F; Scougall CA; Grosse A; Qiao Q; Ajilian BB; Reaiche-Miller G; Finnie J; Werner M; Broering R; Schlaak JF; Vaillant A; Jilbert AR
    PLoS One; 2015; 10(11):e0140909. PubMed ID: 26560490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duck hepatitis B virus infection of non-hepatocytes.
    Walter E; Teubner K; Blum HE; Offensperger WB; Offensperger S; Gerok W
    Liver; 1991 Feb; 11(1):53-62. PubMed ID: 2046495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
    Feng F; Teoh CQ; Qiao Q; Boyle D; Jilbert AR
    Vaccine; 2010 Oct; 28(46):7436-43. PubMed ID: 20833122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
    Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
    J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
    Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
    Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of surgical immunomodulation on liver inflammation and clearance of DHBV infection.
    Vickery K; Tohidi-Esfahani R; Pouliopoulos J; Welschinger R; Dixon R; Deva A; Cossart Y
    J Med Virol; 2006 Dec; 78(12):1572-8. PubMed ID: 17063509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
    Yao Y; Tang N; Huang A
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.